Pathway
Genomics Corporation, a San Diego-based CLIA and CAP accredited
clinical laboratory that offers genetic testing services globally,
announced that former U.S. Representative and Secretary of Agriculture
Dan Glickman joined its strategic advisory board.
“We’re honored to have Secretary Glickman as part of our advisory
board,” said Jim Plante, Pathway Genomics’ founder and CEO. “In his 25
years in public service in Congress and as an advisor to the President
as Cabinet Member, Dan Glickman distinguished himself as a
solutions-oriented leader with impeccable integrity. His many
accomplishments over that time speak for themselves, and we are
extremely fortunate to now benefit from his vast experience.”
Prior to his appointment as Secretary of Agriculture from 1995 until
2001, Glickman served for 18 years in the U.S. House of Representatives
representing the 4th Congressional District of Kansas. During his tenure
in the House, Glickman emphasized the roles of diet and nutrition in
preventing diseases and promoting public health. In 2012 and 2013,
Glickman chaired an Institute of Medicine Panel on “Accelerating
Progress in Obesity Prevention.”
“From a national perspective, I’ve been an advocate for increased
prevention as it is clear by all measures that an ounce of prevention is
worth a pound of cure,” said Glickman. “Genetics is the new frontier on
prevention and Pathway is at the forefront of bringing this new
information to physicians so that they can identify the best prevention
program for a patient based on their overall risk factors.”
Glickman served as Chairman of the Motion Picture Association of
America, Inc. (MPAA) from 2004 until 2010, and is the Executive Director
of the Aspen Institute Congressional Program, a nongovernmental,
nonpartisan educational program for members of the United States
Congress.
About Pathway Genomics Corporation
As a CLIA and CAP accredited clinical laboratory based in San Diego,
California, Pathway
Genomics provides physicians with actionable and accurate genetic
information to improve or maintain health and wellness of their
patients. Since its founding in 2008, Pathway
Genomics has become known for its dedication to innovation and
commitment to medical responsibility – making it a leader in the
commercial genetic testing industry.
Pathway
Genomics’ testing services cover a variety of conditions including cancer
risk, cardiac
health, inherited
diseases, nutrition
and exercise response, as well as drug response for specific
medications including those used in pain
management and mental
health. For more about Pathway
Genomics, visit www.pathway.com.
Copyright Business Wire 2014